Long-term culture of primary human lymphoblastic leukemia cells in the absence of serum or hematopoietic growth factors

Experimental Hematology

Volumn 37, Issue 3, 2009, Pages 376-385

  Nijmeijer, Bart A ^a   Szuhai, Karoly ^a   Goselink, Henriëtte M ^a   van Schie, Marianke L J ^a   van der Burg, Marja ^a   de Jong, Danielle ^a   Marijt, Erik W ^a   Ottmann, Oliver G ^b   Willemze, Roel ^a   Falkenburg, J H Frederik ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; HEMOPOIETIC GROWTH FACTOR; IMATINIB; ONCOPROTEIN;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; CELL LINEAGE; CELL PROLIFERATION; CHROMOSOME TRANSLOCATION; CYTOGENETICS; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHATIC LEUKEMIA; MOUSE; MYELOID LEUKEMIA; NONHUMAN; PRIORITY JOURNAL;

CELL CULTURE TECHNIQUES; CELL PROLIFERATION; CULTURE MEDIA, SERUM-FREE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LEUKEMIA, B-CELL; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; TIME FACTORS;

EID: 59749083730     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2008.11.002     Document Type: Article

References (33)

1. Pui C.H., and Evans W.E. Treatment of acute lymphoblastic leukemia. N Engl J Med 354 (2006) 166-178
2. Piccaluga P.P., Paolini S., and Martinelli G. Tyrosine kinase inhibitors for the treatment of Philadelphia chromosome-positive adult acute lymphoblastic leukemia. Cancer 110 (2007) 1178-1186
3. Claviez A., Eckert C., Seeger K., et al. Rituximab plus chemotherapy in children with relapsed or refractory CD20-positive B-cell precursor acute lymphoblastic leukemia. Haematologica 91 (2006) 272-273
4. Drexler H.G., and Minowada J. History and classification of human leukemia-lymphoma cell lines. Leuk Lymphoma 31 (1998) 305-316
5. Drexler H.G., MacLeod R.A., and Uphoff C.C. Leukemia cell lines: in vitro models for the study of Philadelphia chromosome-positive leukemia. Leuk Res 23 (1999) 207-215
6. MacLeod R.A., and Drexler H.G. Conservation of unreposited cell lines. Cytogenet Genome Res 116 (2007) 152
7. Drexler H.G., and Matsuo Y. Guidelines for the characterization and publication of human malignant hematopoietic cell lines. Leukemia 13 (1999) 835-842
8. Deutsche Sammlung von Mikroorganismen und Zellkulturen. Available at: http://www.dsmz.de/. Accessed September 2008.
9. Rosenfeld C., Goutner A., Venuat A.M., et al. An effect human leukaemic cell line: Reh. Eur J Cancer 13 (1977) 377-379
10. Nishii K., Katayama N., Miwa H., et al. Survival of human leukaemic B-cell precursors is supported by stromal cells and cytokines: association with the expression of bcl-2 protein. Br J Haematol 105 (1999) 701-710
11. Bruserud O., Glenjen N., Ryningen A., and Ulvestad E. In vitro culture of human acute lymphoblastic leukemia (ALL) cells in serum-free media; a comparison of native ALL blasts, ALL cell lines and virus-transformed B cell lines. Leuk Res 27 (2003) 455-464
12. Makrynikola V., Kabral A., and Bradstock K.F. Effects of recombinant human cytokines on precursor-B acute lymphoblastic leukemia cells. Exp Hematol 19 (1991) 674-679
13. Eder M., Ottmann O.G., Hansen-Hagge T.E., et al. In vitro culture of common acute lymphoblastic leukemia blasts: effects of interleukin-3, interleukin-7, and accessory cells. Blood 79 (1992) 3274-3284
14. Gluck U., Zipori D., Wetzler M., et al. Long-term proliferation of human leukemia cells induced by mouse stroma. Exp Hematol 17 (1989) 398-404
15. Manabe A., Coustan-Smith E., Behm F.G., Raimondi S.C., and Campana D. Bone marrow-derived stromal cells prevent apoptotic cell death in B-lineage acute lymphoblastic leukemia. Blood 79 (1992) 2370-2377
16. Bradstock K., Bianchi A., Makrynikola V., Filshie R., and Gottlieb D. Long-term survival and proliferation of precursor-B acute lymphoblastic leukemia cells on human bone marrow stroma. Leukemia 10 (1996) 813-820
17. Nishigaki H., Ito C., Manabe A., et al. Prevalence and growth characteristics of malignant stem cells in B-lineage acute lymphoblastic leukemia. Blood 89 (1997) 3735-3744
18. Cox C.V., Evely R.S., Oakhill A., Pamphilon D.H., Goulden N.J., and Blair A. Characterization of acute lymphoblastic leukemia progenitor cells. Blood 104 (2004) 2919-2925
19. Cox C.V., and Blair A. A primitive cell origin for B-cell precursor ALL?. Stem Cell Rev 1 (2005) 189-196
20. Goselink H.M., van Damme J., Hiemstra P.S., et al. Colony growth of human hematopoietic progenitor cells in the absence of serum is supported by a proteinase inhibitor identified as antileukoproteinase. J Exp Med 184 (1996) 1305-1312
21. Singh N.J., and Schwartz R.H. The strength of persistent antigenic stimulation modulates adaptive tolerance in peripheral CD4+ T cells. J Exp Med 198 (2003) 1107-1117
22. Szuhai K., and Tanke H.J. COBRA: combined binary ratio labeling of nucleic-acid probes for multi-color fluorescence in situ hybridization karyotyping. Nat Protoc 1 (2006) 264-275
23. Mitelman F. ISCN 1995: An International System for Human Cytogenetic Nomenclature (2008), S Karger, Basel, Switzerland
24. Niesters H.G., van E.J., Fries E., Wolthers K.C., Cornelissen J., and Osterhaus A.D. Development of a real-time quantitative assay for detection of Epstein-Barr virus. J Clin Microbiol 38 (2000) 712-715
25. Nijmeijer B.A., Mollevanger P., Zelderen-Bhola S.L., Kluin-Nelemans H.C., Willemze R., and Falkenburg J.H.F. Monitoring of engraftment and progression of acute lymphoblastic leukemia in individual NOD/SCID mice. Exp Hematol 29 (2001) 322-329
26. Baeumler J., Szuhai K., Falkenburg J.H.F., van Schie M.L.J., Ottmann O.G., and Nijmeijer B.A. Establishment and cytogenetic characterization of a human acute lymphoblastic leukemia cell line (ALL-VG) with ETV6/ABL1 rearrangement. Cancer Genet Cytogenet 185 (2008) 37-42
27. Campana D., Iwamoto S., Bendall L., and Bradstock K. Growth requirements and immunophenotype of acute lymphoblastic leukemia progenitors. Blood 105 (2005) 4150
28. Castor A., Nilsson L., Astrand-Grundstrom I., et al. Distinct patterns of hematopoietic stem cell involvement in acute lymphoblastic leukemia. Nat Med 11 (2005) 630-637
29. Foa R., Vitale A., Mancini M., et al. E2A-PBX1 fusion in adult acute lymphoblastic leukaemia: biological and clinical features. Br J Haematol 120 (2003) 484-487
30. Voss J., Posern G., Hannemann J.R., et al. The leukaemic oncoproteins Bcr-Abl and Tel-Abl (ETV6/Abl) have altered substrate preferences and activate similar intracellular signalling pathways. Oncogene 19 (2000) 1684-1690
31. Cambier N., Chopra R., Strasser A., Metcalf D., and Elefanty A.G. BCR-ABL activates pathways mediating cytokine independence and protection against apoptosis in murine hematopoietic cells in a dose-dependent manner. Oncogene 16 (1998) 335-348
32. Primo D., Tabernero M.D., Perez J.J., et al. Genetic heterogeneity of BCR/ABL+ adult B-cell precursor acute lymphoblastic leukemia: impact on the clinical, biological and immunophenotypical disease characteristics. Leukemia 19 (2005) 713-720
33. Calabretta B., and Perrotti D. The biology of CML blast crisis. Blood 103 (2004) 4010-4022